LAUSR

Clinical Outcomes of Clofazimine Use for Rapidly Growing Mycobacterial Infections

Sign Up to like & get
recommendations!
1 Published in 2019 at "Open Forum Infectious Diseases"

DOI: 10.1093/ofid/ofz456

Abstract: Rapidly growing mycobacteria (RGM) have high rates of intrinsic antibiotic resistance and require prolonged antibiotic therapies associated with considerable toxicity. Less toxic and more effective therapies are needed. One promising agent is clofazimine (CFZ), an… read more here.

Keywords: cfz; clinical outcomes; treatment; infection ... See more keywords